Wyeth Receives Approval for Arthritis Drug

  • Posted on 23 July 2009

Wyeth has received approval from the Japanese Ministry of Health, Labor and Welfare to add the indication of treating polyarticular Juvenile Idiopathic Arthritis (JIA) to “Enbrel 25mg for SC Injection,” (etanercept).

The company also received approval for the addition of “Enbrel 10mg for SC Injection,” a 10-mg dose of the product.

  • Share this article
  • Got more on this story? Email PharmaAsia